These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37699580)

  • 1. Fluoroquinolone-associated adverse events of interest among hospitalized veterans affairs patients with community-acquired pneumonia who were treated with a fluoroquinolone: A focus on tendonitis, Clostridioides difficile infection, and aortic aneurysm.
    Patel N; Gorseth A; Belfiore G; Stornelli N; Lowry C; Thomas L
    Pharmacotherapy; 2024 Jan; 44(1):49-60. PubMed ID: 37699580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of fluoroquinolones or cephalosporin plus macrolide with
    Patel P; Deshpande A; Yu PC; Imrey PB; Lindenauer PK; Zilberberg MD; Haessler S; Rothberg MB
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):47-54. PubMed ID: 35440348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of doxycycline on Clostridioides difficile infection in patients hospitalized with community-acquired pneumonia.
    O'Leary AL; Chan AK; Wattengel BA; Xu J; Mergenhagen KA
    Am J Infect Control; 2024 Mar; 52(3):280-283. PubMed ID: 37921728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational study in a single institute in Japan: How many community-onset pneumonia patients would have Clostridioides difficile infections after treatment?
    Asai N; Sakanashi D; Suematsu H; Kato H; Shiota A; Hagihara M; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2020 Oct; 26(10):1104-1106. PubMed ID: 32713744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Tendon Injury in Patients Treated With Fluoroquinolone (FQ) Versus Non-Fluoroquinolone Antibiotics for Community-Acquired Pneumonia (CAP).
    Fleming VH; Xu J; Chen X; Hall D; Southwood RL
    Ann Pharmacother; 2024 Aug; 58(8):771-780. PubMed ID: 37946374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient fluoroquinolone use in Veterans' Affairs hospitals is a predictor of
    Silva SY; Wilson BM; Redmond SN; Donskey CJ
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):57-62. PubMed ID: 32962774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection.
    Lodise TP; Mistry R; Young K; LaPensee K
    Clin Drug Investig; 2021 Mar; 41(3):269-275. PubMed ID: 33604769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic-Specific Risk for Community-Acquired
    Zhang J; Chen L; Gomez-Simmonds A; Yin MT; Freedberg DE
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0112922. PubMed ID: 36377887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of aortic aneurysm and dissection following exposure to fluoroquinolones, common antibiotics, and febrile illness using a self-controlled case series study design: Retrospective analyses of three large healthcare databases in the US.
    Londhe AA; Holy CE; Weaver J; Fonseca S; Villasis A; Fife D
    PLoS One; 2021; 16(8):e0255887. PubMed ID: 34398907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omadacycline and
    Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH
    Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration.
    Felsen CB; Dodds Ashley ES; Barney GR; Nelson DL; Nicholas JA; Yang H; Aydelotte ME; Karlic A; Nicholas NC; Petrone KK; Pine RD; Schabel SL; Medina-Walpole A; Dumyati GK
    J Am Med Dir Assoc; 2020 Jan; 21(1):55-61.e2. PubMed ID: 31888865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Clostridium difficile-associated diarrhea with a drug formulary change in preferred fluoroquinolones.
    Walbrown MA; Aspinall SL; Bayliss NK; Stone RA; Cunningham F; Squier CL; Good CB
    J Manag Care Pharm; 2008; 14(1):34-40. PubMed ID: 18240880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
    McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
    Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm.
    Newton ER; Akerman AW; Strassle PD; Kibbe MR
    JAMA Surg; 2021 Mar; 156(3):264-272. PubMed ID: 33404647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
    Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
    JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia.
    Chalmers JD; Akram AR; Singanayagam A; Wilcox MH; Hill AT
    J Infect; 2016 Jul; 73(1):45-53. PubMed ID: 27105657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile Infection Following Spine Surgery: Incidence, Risk Factors, and Association With Preoperative Antibiotic Use.
    Bell J; Vatani J; Raad M; Labaran L; Puvanesarajah V; Hassanzadeh H
    Spine (Phila Pa 1976); 2020 Nov; 45(22):1572-1579. PubMed ID: 32756273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.
    Garg M; Venugopalan V; Vouri SM; Diaby V; Iovine NM; Park H
    Pharmacotherapy; 2023 Sep; 43(9):883-893. PubMed ID: 37381584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder.
    Ramanathan S; Johnson S; Burns SP; Kralovic SM; Goldstein B; Smith B; Gerding DN; Evans CT
    Am J Infect Control; 2014 Feb; 42(2):168-73. PubMed ID: 24485372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
    Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
    JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.